Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Equities researchers at Zacks Research lifted their Q3 2026 earnings per share (EPS) estimates for shares of Phibro Animal Health in a report released on Tuesday, December 10th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.35 for the quarter, up from their previous estimate of $0.33. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.62 per share.
A number of other research analysts have also weighed in on the stock. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 price objective for the company. StockNews.com lowered Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a report on Friday, December 6th. Bank of America boosted their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the company an "underperform" rating in a research note on Friday, August 30th. Finally, Barclays upped their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a research report on Tuesday, November 12th.
View Our Latest Stock Analysis on Phibro Animal Health
Phibro Animal Health Stock Performance
NASDAQ PAHC traded down $1.00 during trading on Friday, hitting $22.88. 62,532 shares of the company's stock traded hands, compared to its average volume of 157,302. The stock has a market capitalization of $926.64 million, a price-to-earnings ratio of 55.54, a PEG ratio of 0.62 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. The business has a 50 day moving average of $23.58 and a 200-day moving average of $20.52. Phibro Animal Health has a 12-month low of $10.03 and a 12-month high of $25.98.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.10%. The ex-dividend date is Wednesday, November 27th. Phibro Animal Health's dividend payout ratio (DPR) is currently 111.63%.
Hedge Funds Weigh In On Phibro Animal Health
Large investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets increased its position in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after acquiring an additional 729 shares during the period. CWM LLC boosted its position in Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company's stock valued at $37,000 after acquiring an additional 1,035 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in Phibro Animal Health by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company's stock valued at $200,000 after acquiring an additional 1,063 shares in the last quarter. China Universal Asset Management Co. Ltd. grew its holdings in shares of Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock worth $88,000 after acquiring an additional 1,522 shares during the period. Finally, Public Sector Pension Investment Board raised its position in shares of Phibro Animal Health by 6.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 44,796 shares of the company's stock worth $751,000 after acquiring an additional 2,583 shares in the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.
Phibro Animal Health Company Profile
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
